Close Menu

NEW YORK ─ The International Atomic Energy Agency (IAEA) said Wednesday that Takeda Pharmaceutical will donate 500 million yen ($4.7 million) to support the agency's initiative to help countries combat the COVID-19 pandemic, which involves the supply of RT-PCR tests to laboratories around the world.

The financial contribution from the Tokyo-based biopharmaceutical firm will enable the IAEA to increase its emergency assistance to agency member states that are in need of quick and reliable diagnostic methods to contain the coronavirus, IAEA said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.


This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.